{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF09793",
      "entity_text" : "AD",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4893",
      "entity_text" : "Prazosin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Prazosin appears to reduce the severity of AD, lowering peak systolic blood pressures by about 40 mmHg during PVS in patients with SCI, without affecting resting blood pressure.",
  "reading_complete" : "2020-08-04T13:20:26Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:18:22Z",
  "trigger" : "reduce",
  "evidence" : [ "Prazosin appears to reduce the severity of AD" ],
  "pmc_id" : "4739989",
  "score" : 0
}